老年腹膜后肉瘤的多脏器联合切除术
研究分析2008年1月1日至2014年12月31日转诊的385例原发性局限性腹膜后肉瘤患者,比较>65岁与<65岁两组的手术比例和肿瘤学结局。>65岁患者未手术比例更高(41.8% vs 12.0%),围手术期并发症更高(28.3% vs 9.5%),但围手术期死亡和肿瘤学结局无差异;非手术患者中位生存显著短于手术患者(15 vs 91个月,p<0.001)。
要点
- >65岁患者未手术比例41.8%,高于<65岁患者的12.0%。
- >65岁患者围手术期并发症28.3%,高于<65岁患者的9.5%。
- 两组围手术期死亡和肿瘤学结局无差异。
核心结论
- 老年原发性腹膜后肉瘤行扩大切除术可获得与年轻患者相当的肿瘤学结局,但并发症发生率更高。
- 不适合手术的患者结局差,与年龄无关。
研究设计与样本
- 研究识别2008年1月1日至2014年12月31日转诊的原发性局限性腹膜后肉瘤患者,比较>65岁与<65岁两组。
- 共识别385例患者,281例(73.0%)接受手术。
主要发现
- 最常见组织学亚型为去分化脂肪肉瘤(40.3%)、高分化脂肪肉瘤(19.5%)和平滑肌肉瘤(18.2%)。
- >65岁组未手术比例41.8%,<65岁组12.0%。
- 不可切除肿瘤比例两组相似(17.5% vs 11.0%)。
- 因合并症非手术管理>65岁组13.4%,<65岁组0.5%;因患者选择非手术管理>65岁组8.2%,<65岁组0.5%。
- >65岁组围手术期并发症28.3%,<65岁组9.5%;围手术期死亡或肿瘤学结局两组无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retroperitoneal sarcomas occur in an anatomically complex location often involving several adjacent organs. Surgery with multivisceral resection constitutes the mainstay of curative therapy. This study sought to characterise the morbidity and oncological outcomes of surgery for retroperitoneal sarcoma in an elderly population. METHODS: Patients with primary, localised retroperitoneal sarcoma referred between 1st January 2008 and 31st December 2014 were identified from multidisciplinary meeting records. The proportion of patients proceeding to surgery and oncological outcomes were compared between two groups-those aged >65 years and <65 years. RESULTS: A total of 385 patients were identified. The most common histological subtypes were de-differentiated liposarcoma (40.3%), well-differentiated liposarcoma (19.5%) and leiomyosarcoma (18.2%). A greater proportion of patients aged >65 years did not undergo surgery (41.8% versus 12.0%). The rates of irresectable tumours were similar between cohorts (17.5% versus 11.0%). However, non-operative management due to comorbidities (13.4% versus 0.5%) or patient choice (8.2% versus 0.5%) was more common in patients aged >65 years. 281 patients (73.0%) proceeded to surgery. Patients aged >65 years had a higher rate of peri-operative morbidity (28.3% versus 9.5%), although no difference in peri-operative mortality or oncological outcomes was noted between age groups. The survival of patients managed non-operatively was significantly shorter than those undergoing surgery (median survival 15 versus 91 months, p < 0.001). CONCLUSION: Extended resections for primary retroperitoneal sarcoma in the elderly achieve comparable oncological outcomes but with increased rates of morbidity when compared with younger patients. The outcomes of patients unsuitable for surgery are poor regardless of age.
引用
- Smith HG, Thomas JM, Smith MJ, et al. Multivisceral resection of retroperitoneal sarcomas in the elderly. Eur J Cancer. 2016. PMID: 27821314. doi:10.1016/j.ejca.2016.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。